101
Participants
Start Date
December 3, 2015
Primary Completion Date
September 6, 2017
Study Completion Date
September 6, 2017
BioFoam® Surgical Matrix
Complete hemostasis is achieved by direct application of BioFoam® (Cryolife Inc., Kennesaw, GA) to the transection surface area of the liver. In addition, the surgeon may use conventional methods such as argon beam coagulation and warm sponges. If more than one syringe of BioFoam® is required to cover the entire transection surface area, a second syringe maybe used. BioFoam® Surgical Matrix will be used according to the supplier's instructions.
Conservative hemostasis
Complete hemostasis will be achieved without the use of topical agents
Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Germany, Dresden
Collaborators (1)
CryoLife, Inc.
INDUSTRY
Technische Universität Dresden
OTHER